Mylan selling generic version of Pfizer’s Detrol

Bookmark and Share
Make text smaller Make text larger

CANONSBURG – Mylan Inc. said Thursday that it is now selling a generic version of Pfizer Inc.’s overactive bladder drug Detrol.


The Southpointe-based company said it started shipping its generic after receiving approval from the Food and Drug Administration. It said U.S. sales of Detrol, or tolterodine, totaled $61.5 million over the year ended Sept. 30.


Mylan plans to start selling a generic version of Detrol LA, a long-acting version of the drug, in early 2014 as part of an agreement with Pfizer. Annual U.S. sales of Detrol LA are around $600 million.


Shares of Pittsburgh-based Mylan rose 13 cents to $27.32 in midday trading after rising as high as $27.45 earlier in the session, its highest since October 2003.


Bookmark and Share Make text smaller Make text larger
comments powered by Disqus
Download our new e-Edition apps

Most Popular
August
2014
Wednesday
20
S M T W T F S
27 28 29 30 31 1 2
3 4 5 6 7 8 9
24 25 26 27 28 29 30
31 1 2 3 4 5 6
O-R's Poll Question of the Day